These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab. Schmidtko J; Peine S; El-Housseini Y; Pascual M; Meier P Am J Kidney Dis; 2013 Feb; 61(2):289-99. PubMed ID: 23141475 [TBL] [Abstract][Full Text] [Related]
27. [Hemolytic anemia, myocardial infarction and xenotransplantation: what do they have in common?]. Schifferli JA Schweiz Med Wochenschr; 1995 Nov; 125(46):2217-25. PubMed ID: 8525341 [TBL] [Abstract][Full Text] [Related]
28. [Management of pregnancy and delivery in patients with paroxysmal nocturnal hemoglobinuria]. Usuki K Rinsho Ketsueki; 2015 Jul; 56(7):785-94. PubMed ID: 26251141 [TBL] [Abstract][Full Text] [Related]
29. The role of complement inhibition in PNH. Hillmen P Hematology Am Soc Hematol Educ Program; 2008; ():116-23. PubMed ID: 19074068 [TBL] [Abstract][Full Text] [Related]
30. [Coagulation and complement crosstalk: molecular mechanisms of complement-mediated diseases]. Tsujimoto H; Inoue N Rinsho Ketsueki; 2024; 65(6):576-583. PubMed ID: 38960659 [TBL] [Abstract][Full Text] [Related]
31. Pregnancy-induced hemolytic anemia with a possible immune-related mechanism. Katsuragi S; Sameshima H; Omine M; Ikenoue T Obstet Gynecol; 2008 Feb; 111(2 Pt 2):528-9. PubMed ID: 18239010 [TBL] [Abstract][Full Text] [Related]
32. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH). Shichishima T Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038 [TBL] [Abstract][Full Text] [Related]
34. [Hemolytic disorders and venous thrombosis: An update]. Lecouffe-Desprets M; Graveleau J; Artifoni M; Connault J; Agard C; Pottier P; Hamidou M; Néel A Rev Med Interne; 2019 Apr; 40(4):232-237. PubMed ID: 30773236 [TBL] [Abstract][Full Text] [Related]
35. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria. Bessler M; Hiken J Hematology Am Soc Hematol Educ Program; 2008; ():104-10. PubMed ID: 19074066 [TBL] [Abstract][Full Text] [Related]
36. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137 [TBL] [Abstract][Full Text] [Related]
37. A review of the alternative pathway of complement and its relation to HELLP syndrome: is it time to consider HELLP syndrome a disease of the alternative pathway. Vaught AJ; Braunstein E; Chaturvedi S; Blakemore K; Brodsky RA J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1392-1400. PubMed ID: 32338085 [TBL] [Abstract][Full Text] [Related]
38. Increasing Incidence and Prevalence of Acquired Hemolytic Anemias in Denmark, 1980-2016. Hansen DL; Möller S; Andersen K; Gaist D; Frederiksen H Clin Epidemiol; 2020; 12():497-508. PubMed ID: 32547241 [TBL] [Abstract][Full Text] [Related]